Total Payments
$12,849
2024 Payments
$10,009
Companies
11
Transactions
48
Payment Breakdown by Category
Consulting$10,350 (80.6%)
Food & Beverage$1,828 (14.2%)
Travel$669.96 (5.2%)
Education$0.83 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,350 | 4 | 80.6% |
| Food and Beverage | $1,828 | 39 | 14.2% |
| Travel and Lodging | $669.96 | 4 | 5.2% |
| Education | $0.83 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | $11,735 | 18 | $0 (2024) |
| ABBVIE INC. | $392.88 | 10 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $195.32 | 4 | $0 (2019) |
| Janssen Biotech, Inc. | $159.44 | 2 | $0 (2024) |
| Retrophin, Inc. | $114.01 | 4 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $101.50 | 3 | $0 (2024) |
| GENZYME CORPORATION | $44.23 | 2 | $0 (2024) |
| Shire North American Group Inc | $34.53 | 2 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $28.63 | 1 | $0 (2023) |
| Travere Therapeutics, Inc. | $22.28 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,009 | 21 | Mirum Pharmaceuticals, Inc. ($9,732) |
| 2023 | $109.35 | 4 | Mirum Pharmaceuticals, Inc. ($52.74) |
| 2022 | $2,007 | 4 | Mirum Pharmaceuticals, Inc. ($1,950) |
| 2020 | $110.78 | 2 | AbbVie Inc. ($110.78) |
| 2019 | $283.86 | 9 | AbbVie, Inc. ($208.33) |
| 2018 | $270.65 | 5 | Alexion Pharmaceuticals, Inc. ($171.83) |
| 2017 | $57.36 | 3 | AbbVie, Inc. ($41.92) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $49.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $131.09 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Immunology | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $312.26 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $156.78 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $116.46 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $69.64 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $46.33 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $143.48 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $118.66 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $28.26 | General |
| Category: Alagille syndrome | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Immunology | ||||||
| 06/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Immunology | ||||||
| 04/12/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Alagille syndrome | ||||||
| 04/12/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $172.66 | General |
| Category: Alagille syndrome | ||||||
| 04/12/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $86.00 | General |
| Category: Alagille syndrome | ||||||
| 04/12/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $65.00 | General |
| Category: Alagille syndrome | ||||||
| 04/12/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $16.72 | General |
| Category: Alagille syndrome | ||||||
| 02/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/06/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Alagille syndrome | ||||||
| 07/07/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Alagille syndrome | ||||||
| 05/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
About Dr. Katherine Mcgoogan, MD
Dr. Katherine Mcgoogan, MD is a Pediatrics healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407051527.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Mcgoogan, MD has received a total of $12,849 in payments from pharmaceutical and medical device companies, with $10,009 received in 2024. These payments were reported across 48 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($10,350).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Gastroenterology, Pediatric Gastroenterology
- Location Jacksonville, FL
- Active Since 06/19/2007
- Last Updated 09/15/2011
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1407051527
Products in Payments
- Livmarli (Drug) $9,785
- GATTEX (Drug) $136.03
- TREMFYA (Drug) $131.09
- Strensiq (Drug) $125.00
- HUMIRA (Biological) $110.78
- Humira (Biological) $88.49
- (815) Thiola (Drug) $81.06
- DUPIXENT (Biological) $72.86
- Kanuma (Drug) $70.32
- (820) Cholbam (Drug) $32.95
- STELARA (Biological) $28.35
- Cholbam (Drug) $22.28
- SUCRAID (Drug) $21.01
- MAVYRET (Drug) $14.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Jacksonville
Ryan Cantville, D.o, D.O
Pediatrics — Payments: $104,502
Pediatrics $104,502
Dr. Mobeen Rathore, M.d, M.D
Pediatrics — Payments: $39,707
Pediatrics $39,707
Dr. Robert English, M.d, M.D
Pediatrics — Payments: $12,985
Pediatrics $12,985
Thomas Moon, M.d, M.D
Pediatrics — Payments: $6,275
Pediatrics $6,275
Dr. Deepica Reddy, Md, MD
Pediatrics — Payments: $6,121
Pediatrics $6,121
Rustin Buffington, Md, MD
Pediatrics — Payments: $4,620
Pediatrics $4,620